Encouraging results from phase 1/2 COVID-19 vaccine trials

Naor Bar-Zeev; William J. Moss

doi:10.1016/S0140-6736(20)31611-1

Encouraging results from phase 1/2 COVID-19 vaccine trials

Naor Bar-Zeev, William J. Moss

Bloomberg School of Public Health

Research output: Contribution to journal › Comment/debate › peer-review

16 Scopus citations

Original language	English (US)
Pages (from-to)	448-449
Number of pages	2
Journal	The Lancet
Volume	396
Issue number	10249
DOIs	https://doi.org/10.1016/S0140-6736(20)31611-1
State	Published - Aug 15 2020

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/S0140-6736(20)31611-1

Cite this

@article{7211f8fd05274b90b8abdf10c8b7690f,

title = "Encouraging results from phase 1/2 COVID-19 vaccine trials",

author = "Naor Bar-Zeev and Moss, {William J.}",

year = "2020",

month = aug,

day = "15",

doi = "10.1016/S0140-6736(20)31611-1",

language = "English (US)",

volume = "396",

pages = "448--449",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "10249",

}

TY - JOUR

T1 - Encouraging results from phase 1/2 COVID-19 vaccine trials

AU - Bar-Zeev, Naor

AU - Moss, William J.

PY - 2020/8/15

Y1 - 2020/8/15

UR - http://www.scopus.com/inward/record.url?scp=85088090372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85088090372&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(20)31611-1

DO - 10.1016/S0140-6736(20)31611-1

M3 - Comment/debate

C2 - 32702300

AN - SCOPUS:85088090372

SN - 0140-6736

VL - 396

SP - 448

EP - 449

JO - The Lancet

JF - The Lancet

IS - 10249

ER -

Encouraging results from phase 1/2 COVID-19 vaccine trials

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this